An anti-inflammatory active ingredients in Poriae cutis: Screening based on network pharmacology.

IF 1.5 4区 医学 Q4 CHEMISTRY, MEDICINAL
Pharmazie Pub Date : 2024-05-15 DOI:10.1691/ph.2024.3647
Runze Jin, Zitong Zhao, Qing Zhang, Y U Sun, Wei Wang, Daiyin Peng, Sihui Nian, Lingyun Zhou
{"title":"An anti-inflammatory active ingredients in <i>Poriae cutis</i>: Screening based on network pharmacology.","authors":"Runze Jin, Zitong Zhao, Qing Zhang, Y U Sun, Wei Wang, Daiyin Peng, Sihui Nian, Lingyun Zhou","doi":"10.1691/ph.2024.3647","DOIUrl":null,"url":null,"abstract":"<p><p>Hyperuricemia (HUA) is a disorder of uric acid metabolism, which can lead to the formation of gouty arthritis, kidney inflammation and other damages. Previous studies have found that the alcohol extract of <i>Poria cutis</i> can reduce the level of uric acid and protect against kidney injury. Based on network pharmacology, the core targets and main active components of <i>P. cutis</i> intervention in HUA were determined. Most of the potential active ingredients are triterpenoid acids such as tumulosic acid (TA) and eburicoic acid (EA), and the potential targets are TNF and IL-6, which are associated with inflammation. <i>In vitro</i> experiments have shown that TA can significantly inhibit the release of NO, TNF-α and IL-6 in inflammatory RAW264.7 cell culture medium and the expression of TNF-α and IL-6 in RAW264.7 cells. This study suggests that TA based on network pharmacological screening has obvious anti-inflammatory effect on inflammatory RAW264.7 cells and is a promising anti-inflammatory compound.</p>","PeriodicalId":20145,"journal":{"name":"Pharmazie","volume":"79 3","pages":"72-81"},"PeriodicalIF":1.5000,"publicationDate":"2024-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmazie","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1691/ph.2024.3647","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Hyperuricemia (HUA) is a disorder of uric acid metabolism, which can lead to the formation of gouty arthritis, kidney inflammation and other damages. Previous studies have found that the alcohol extract of Poria cutis can reduce the level of uric acid and protect against kidney injury. Based on network pharmacology, the core targets and main active components of P. cutis intervention in HUA were determined. Most of the potential active ingredients are triterpenoid acids such as tumulosic acid (TA) and eburicoic acid (EA), and the potential targets are TNF and IL-6, which are associated with inflammation. In vitro experiments have shown that TA can significantly inhibit the release of NO, TNF-α and IL-6 in inflammatory RAW264.7 cell culture medium and the expression of TNF-α and IL-6 in RAW264.7 cells. This study suggests that TA based on network pharmacological screening has obvious anti-inflammatory effect on inflammatory RAW264.7 cells and is a promising anti-inflammatory compound.

茯苓中的抗炎活性成分:基于网络药理学的筛选
高尿酸血症(HUA)是一种尿酸代谢紊乱的疾病,可导致痛风性关节炎、肾脏炎症和其他损害的形成。以往的研究发现,茯苓的醇提取物可以降低尿酸水平,保护肾脏免受损伤。基于网络药理学,确定了茯苓干预 HUA 的核心靶点和主要活性成分。其中大部分潜在活性成分为三萜类酸,如瘤烷酸(TA)和桉叶油酸(EA),潜在靶点为与炎症相关的 TNF 和 IL-6。体外实验表明,TA 能显著抑制炎症 RAW264.7 细胞培养基中 NO、TNF-α 和 IL-6 的释放,以及 RAW264.7 细胞中 TNF-α 和 IL-6 的表达。该研究表明,基于网络药理筛选的 TA 对 RAW264.7 炎症细胞具有明显的抗炎作用,是一种很有前途的抗炎化合物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pharmazie
Pharmazie 医学-化学综合
CiteScore
3.10
自引率
0.00%
发文量
56
审稿时长
1.2 months
期刊介绍: The journal DiePharmazie publishs reviews, experimental studies, letters to the editor, as well as book reviews. The following fields of pharmacy are covered: Pharmaceutical and medicinal chemistry; Pharmaceutical analysis and drug control; Pharmaceutical technolgy; Biopharmacy (biopharmaceutics, pharmacokinetics, biotransformation); Experimental and clinical pharmacology; Pharmaceutical biology (pharmacognosy); Clinical pharmacy; History of pharmacy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信